Recent studies have proved that activation of c-Myc could be inhibited by JQ1, a small molecule inhibitor targeting bromodomain proteins (BRDs), resulting in a remarkable inhibition of cancer cell growth and response in many cancer models in mice [24, 25]. Here, MYC is linked to cancer.